{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:35:25Z","timestamp":1787150125462,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"DOI":"10.1007\/s40256-026-00822-8","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:18:58Z","timestamp":1787149138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of \u03b2-Blocker Therapy on Peak VO2 in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7271-4845","authenticated-orcid":false,"given":"Juliana","family":"Giorgi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1461-7185","authenticated-orcid":false,"given":"Pedro Gomes","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena dall Witt","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3261-863X","authenticated-orcid":false,"given":"Giulia","family":"Gaelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6482-5920","authenticated-orcid":false,"given":"Larissa","family":"Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4220-7491","authenticated-orcid":false,"given":"Juan Peres","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7890-2615","authenticated-orcid":false,"given":"Ramon","family":"Huntermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6827-9404","authenticated-orcid":false,"given":"Maria Eduarda","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4298-8649","authenticated-orcid":false,"given":"Caroline O.","family":"Fischer-Bacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"issue":"17","key":"822_CR1","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79(17):e263-421. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"822_CR2","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.jacc.2021.08.073","volume":"78","author":"P Palau","year":"2021","unstructured":"Palau P, Seller J, Dom\u00ednguez E, Sastre C, Ram\u00f3n JM, de La Espriella R, et al. Effect of \u03b2-blocker withdrawal on functional capacity in heart failure and preserved ejection fraction. J Am Coll Cardiol. 2021;78(21):2042\u201356. https:\/\/doi.org\/10.1016\/j.jacc.2021.08.073.","journal-title":"J Am Coll Cardiol"},{"issue":"216","key":"822_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.amjcard.2024.01.023","volume":"1","author":"L Patel","year":"2024","unstructured":"Patel L, Segar MW, Keshvani N, Subramanian V, Pandey A, Chandra A. Association of beta-blocker use with exercise capacity in participants with heart failure with preserved ejection fraction: a post hoc analysis of the RELAX trial. Am J Cardiol. 2024;1(216):48\u201353. https:\/\/doi.org\/10.1016\/j.amjcard.2024.01.023.","journal-title":"Am J Cardiol"},{"key":"822_CR4","doi-asserted-by":"crossref","unstructured":"Weigel FR, Miller A, Patel V, Haas G, Smith S. Effect of beta blockers on exercise capacity, diastolic function, and quality of life in patients with heart failure with preserved ejection fraction: a secondary analysis of INDIE-HFpEF and RELAX [Internet]. medRxiv; 2024 [cited 2025 Nov 11]. p. 2024.09.20.24314104. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2024.09.20.24314104v1.","DOI":"10.1101\/2024.09.20.24314104"},{"issue":"370","key":"822_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ijcard.2022.10.009","volume":"1","author":"S Wernhart","year":"2023","unstructured":"Wernhart S, Papathanasiou M, Mahabadi AA, Rassaf T, Luedike P. Betablockers reduce oxygen pulse increase and performance in heart failure patients with preserved ejection fraction. Int J Cardiol. 2023;1(370):309\u201318. https:\/\/doi.org\/10.1016\/j.ijcard.2022.10.009.","journal-title":"Int J Cardiol"},{"issue":"5","key":"822_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1249\/MSS.0000000000001513","volume":"50","author":"D Montero","year":"2018","unstructured":"Montero D, Flammer AJ. Effect of beta-blocker treatment on $$\\dot{V}$$O2peak in patients with heart failure. Med Sci Sports Exerc. 2018;50(5):889\u201396. https:\/\/doi.org\/10.1249\/MSS.0000000000001513.","journal-title":"Med Sci Sports Exerc"},{"issue":"11","key":"822_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294347","volume":"18","author":"H Fukuta","year":"2023","unstructured":"Fukuta H, Goto T, Kamiya T. Effects of beta-blocker withdrawal in patients with heart failure with preserved ejection fraction: a protocol for systematic review and meta-analysis. PLoS ONE. 2023;18(11):e0294347. https:\/\/doi.org\/10.1371\/journal.pone.0294347.","journal-title":"PLoS ONE"},{"key":"822_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2020;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"822_CR9","doi-asserted-by":"publisher","unstructured":"Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J. 1992;124(4):1017\u201325. https:\/\/doi.org\/10.1016\/0002-8703(92)90986-6. PMID: 1529875.","DOI":"10.1016\/0002-8703(92)90986-6"},{"issue":"11","key":"822_CR10","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358. https:\/\/doi.org\/10.1002\/sim.1186.","journal-title":"Stat Med"},{"key":"822_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"key":"822_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919.","journal-title":"BMJ"},{"issue":"2","key":"822_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/eurjhf\/hfr161","volume":"14","author":"VM Conraads","year":"2012","unstructured":"Conraads VM, Metra M, Kamp O, De Keulenaer GW, Pieske B, Zamorano J, et al. Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. Eur J Heart Fail. 2012;14(2):219\u201325. https:\/\/doi.org\/10.1093\/eurjhf\/hfr161.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"822_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.009124","volume":"15","author":"EB Winzer","year":"2022","unstructured":"Winzer EB, Augstein A, Schauer A, Mueller S, Fischer-Schaepmann T, Goto K, et al. Impact of different training modalities on molecular alterations in skeletal muscle of patients with heart failure with preserved ejection fraction: a substudy of the OptimEx trial. Circ Heart Fail. 2022;15(10):e009124. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.009124.","journal-title":"Circ Heart Fail"},{"issue":"1","key":"822_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/jama.2015.17346","volume":"315","author":"DW Kitzman","year":"2016","unstructured":"Kitzman DW, Brubaker P, Morgan T, Haykowsky M, Hundley G, Kraus WE, et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2016;315(1):36\u201346. https:\/\/doi.org\/10.1001\/jama.2015.17346.","journal-title":"JAMA"},{"issue":"2","key":"822_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.010161","volume":"16","author":"PH Brubaker","year":"2023","unstructured":"Brubaker PH, Nicklas BJ, Houston DK, Hundley WG, Chen H, Molina AJA, et al. A randomized, controlled trial of resistance training added to caloric restriction plus aerobic exercise training in obese heart failure with preserved ejection fraction. Circ Heart Fail. 2023;16(2):e010161. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.122.010161.","journal-title":"Circ Heart Fail"},{"issue":"35","key":"822_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2025.105594","volume":"30","author":"MG Bellicini","year":"2025","unstructured":"Bellicini MG. HFpEF diagnosis: a controversial construct in modern cardiology. JACC Case Rep. 2025;30(35):105594. https:\/\/doi.org\/10.1016\/j.jaccas.2025.105594. (Epub 2025 Oct 8).","journal-title":"JACC Case Rep."},{"issue":"3","key":"822_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/HCR.0000000000000459","volume":"40","author":"S Maldonado-Mart\u00edn","year":"2020","unstructured":"Maldonado-Mart\u00edn S, Brubaker PH, Ozemek C, Jayo-Montoya JA, Becton JT, Kitzman DW. Impact of \u03b2-blockers on heart rate and oxygen uptake during exercise and recovery in older patients with heart failure with preserved ejection fraction. J Cardiopulm Rehabil Prev. 2020;40(3):174\u20137. https:\/\/doi.org\/10.1097\/HCR.0000000000000459.","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"5","key":"822_CR19","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/ejhf.2146","volume":"23","author":"E Wolsk","year":"2021","unstructured":"Wolsk E, Kaye DM, Komtebedde J, Shah SJ, Borlaug BA, Burkhoff D, et al. Determinants and consequences of heart rate and stroke volume response to exercise in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2021;23(5):754\u201364. https:\/\/doi.org\/10.1002\/ejhf.2146.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"822_CR20","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/ejhf.1788","volume":"22","author":"YNV Reddy","year":"2020","unstructured":"Reddy YNV, Rikhi A, Obokata M, Shah SJ, Lewis GD, AbouEzzedine OF, et al. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity. Eur J Heart Fail. 2020;22(6):1009\u201318. https:\/\/doi.org\/10.1002\/ejhf.1788.","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"822_CR21","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/ejhf.862","volume":"19","author":"F Edelmann","year":"2017","unstructured":"Edelmann F, Bobenko A, Gelbrich G, Hasenfuss G, Herrmann-Lingen C, Duvinage A, et al. Exercise training in diastolic heart failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial. Eur J Heart Fail. 2017;19(8):1067\u201374. https:\/\/doi.org\/10.1002\/ejhf.862.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"822_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","volume":"39","author":"JGF Cleland","year":"2018","unstructured":"Cleland JGF, Bunting KV, Flather MD, Altman DG, Holmes J, Coats AJS, et al. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. Eur Heart J. 2018;39(1):26\u201335. https:\/\/doi.org\/10.1093\/eurheartj\/ehx564.","journal-title":"Eur Heart J"},{"issue":"346","key":"822_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f55","volume":"16","author":"S Chatterjee","year":"2013","unstructured":"Chatterjee S, Biondi-Zoccai G, Abbate A, D\u2019Ascenzo F, Castagno D, Van Tassell B, et al. Benefits of \u03b2 blockers in patients with heart failure and reduced ejection fraction: network meta-analysis. BMJ. 2013;16(346):f55. https:\/\/doi.org\/10.1136\/bmj.f55.","journal-title":"BMJ"},{"issue":"5","key":"822_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1001\/jama.2020.10262","volume":"324","author":"SP Murphy","year":"2020","unstructured":"Murphy SP, Ibrahim NE, Januzzi JL. Heart failure with reduced ejection fraction: a review. JAMA. 2020;324(5):488\u2013504. https:\/\/doi.org\/10.1001\/jama.2020.10262.","journal-title":"JAMA"},{"issue":"24","key":"822_CR25","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1016\/j.jacc.2017.04.001","volume":"69","author":"D Kotecha","year":"2017","unstructured":"Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J, et al. Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure. J Am Coll Cardiol. 2017;69(24):2885\u201396. https:\/\/doi.org\/10.1016\/j.jacc.2017.04.001.","journal-title":"J Am Coll Cardiol"},{"key":"822_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ijcard.2017.10.114","volume":"254","author":"D Montero","year":"2018","unstructured":"Montero D, Diaz-Ca\u00f1estro C. Determinants of exercise intolerance in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Int J Cardiol. 2018;254:224\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2017.10.114.","journal-title":"Int J Cardiol"},{"issue":"4","key":"822_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.cjco.2025.01.012","volume":"7","author":"CR Tomczak","year":"2025","unstructured":"Tomczak CR, Foulkes SJ, Weinkauf C, Walesiak D, Wang J, Schmid V, et al. Unraveling heart failure phenotypes: a systematic review and meta-analysis of peak oxygen uptake and its determinants. CJC Open. 2025;7(4):367\u201379. https:\/\/doi.org\/10.1016\/j.cjco.2025.01.012.","journal-title":"CJC Open"},{"issue":"10508","key":"822_CR28","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S0140-6736(25)01592-2","volume":"406","author":"X Rossello","year":"2025","unstructured":"Rossello X, Prescott EIB, Kristensen AMD, Latini R, Fuster V, Fagerland MW, et al. \u03b2 blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials. Lancet. 2025;406(10508):1128\u201337. https:\/\/doi.org\/10.1016\/S0140-6736(25)01592-2.","journal-title":"Lancet"},{"issue":"1","key":"822_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ejhf.1838","volume":"23","author":"S von Haehling","year":"2021","unstructured":"von Haehling S, Arzt M, Doehner W, Edelmann F, Evertz R, Ebner N, et al. Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials. Eur J Heart Fail. 2021;23(1):92\u2013113. https:\/\/doi.org\/10.1002\/ejhf.1838.","journal-title":"Eur J Heart Fail"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-026-00822-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-026-00822-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-026-00822-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:18:59Z","timestamp":1787149139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-026-00822-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":29,"alternative-id":["822"],"URL":"https:\/\/doi.org\/10.1007\/s40256-026-00822-8","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial or non-financial interest in the subject matter or materials discussed in this manuscript","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This is a meta-analysis. The Sirio Libanes Research Ethics Committee has confirmed that no ethical approval is required.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Code availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data used in this meta-analysis were extracted from publicly available sources, including published observational and randomized controlled trials. All relevant data supporting the findings of this study are included within the manuscript and supplementary materials. Due to the nature of this analysis, no new primary data were generated. Additional details can be made available upon reasonable request to the corresponding author.","order":6,"name":"Ethics","label":"Data availability statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors contributed to the study\u2019s conception and design. Material preparation, data collection, and analysis were performed by [Juliana Giorgi], [Pedro Batista], [Larissa Lucena], [Giulia Gaelzer], [Juan Peres], and [Caroline Bacca], [Maria Eduarda Molinari], [Ramon Huntermann], and [Milena Witt]. The first draft of the manuscript was written by [Juliana Giorgi], improved by [Caroline Bacca], and reviewed by [Ramon Huntermann]. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":7,"name":"Ethics","label":"Author contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}